To the top

Page Manager: Webmaster
Last update: 4/19/2017 1:56 PM

Tell a friend about this page
Print version

Magnus Gisslen - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Magnus Gisslen

Professor/ chief physician

Magnus Gisslen
Professor/ chief physician
magnus.gisslen@infect.gu.se

Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: Östra sjukhuset , Göteborg


Department of Infectious Diseases at Institute of Biomedicine (More Information)
Box 480
405 30 Göteborg
0313421000
Visiting Address: Guldhedsgatan 10 A-B , 413 46 Göteborg

Latest publications

Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy.
Albert M Anderson, Kirk A Easley, Nicole Kasher, Donald Franklin, Robert K Heaton et al.
Journal of neurovirology, Journal article 2018
Journal article

Prophylaxis and treatment of HIV-1 infection in pregnancy - Swedish Recommendations 2017
L. Naver, J. Albert, C. Carlander, L. Flamholc, Magnus Gisslén et al.
Infectious Diseases, Journal article 2018
Journal article

Cerebrospinal fluid abacavir concentrations in HIV-positive patients following once-daily administration
A. Calcagno, C. Pinnetti, A. De Nicolo, E. Scarvaglieri, Magnus Gisslén et al.
British Journal of Clinical Pharmacology, Journal article 2018
Journal article

Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations
Erik Sörstedt, C. Carlander, L. Flamholc, B. Hejdeman, V. Svedhem et al.
International Journal of Antimicrobial Agents, Journal article 2018
Journal article

Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in Sweden
E. Andersson, A. Nordquist, J. Esbjörnsson, L. Flamholc, Magnus Gisslén et al.
AIDS, Journal article 2018
Journal article

Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
P. D. Burbelo, R. W. Price, Lars Hagberg, H. Hatano, S. Spudich et al.
Journal of Infectious Diseases, Journal article 2018
Journal article

Structural brain abnormalities in successfully treated HIV infection: associations with disease and cerebrospinal fluid biomarkers.
Rosan A Van Zoest, Jonathan Underwood, Davide De Francesco, Caroline A Sabin, James H Cole et al.
The Journal of infectious diseases, Journal article 2018
Journal article

Immediate initiation of cART is associated with lower levels of cerebrospinal fluid YKL-40, a marker of microglial activation, in HIV-1 infection.
Michael J Peluso, Victor Valcour, Nittaya Phanuphak, Jintanat Ananworanich, James Lk Fletcsher et al.
AIDS (London, England), Journal article 2017
Journal article

Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.
Elham Rahimy, Fang-Yong Li, Lars Hagberg, Dietmar Fuchs, Kevin Robertson et al.
The Journal of infectious diseases, Journal article 2017
Journal article

Showing 1 - 10 of 155

2018

Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy.
Albert M Anderson, Kirk A Easley, Nicole Kasher, Donald Franklin, Robert K Heaton et al.
Journal of neurovirology, Journal article 2018
Journal article

Prophylaxis and treatment of HIV-1 infection in pregnancy - Swedish Recommendations 2017
L. Naver, J. Albert, C. Carlander, L. Flamholc, Magnus Gisslén et al.
Infectious Diseases, Journal article 2018
Journal article

Cerebrospinal fluid abacavir concentrations in HIV-positive patients following once-daily administration
A. Calcagno, C. Pinnetti, A. De Nicolo, E. Scarvaglieri, Magnus Gisslén et al.
British Journal of Clinical Pharmacology, Journal article 2018
Journal article

Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations
Erik Sörstedt, C. Carlander, L. Flamholc, B. Hejdeman, V. Svedhem et al.
International Journal of Antimicrobial Agents, Journal article 2018
Journal article

Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in Sweden
E. Andersson, A. Nordquist, J. Esbjörnsson, L. Flamholc, Magnus Gisslén et al.
AIDS, Journal article 2018
Journal article

Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
P. D. Burbelo, R. W. Price, Lars Hagberg, H. Hatano, S. Spudich et al.
Journal of Infectious Diseases, Journal article 2018
Journal article

Structural brain abnormalities in successfully treated HIV infection: associations with disease and cerebrospinal fluid biomarkers.
Rosan A Van Zoest, Jonathan Underwood, Davide De Francesco, Caroline A Sabin, James H Cole et al.
The Journal of infectious diseases, Journal article 2018
Journal article

2017

Immediate initiation of cART is associated with lower levels of cerebrospinal fluid YKL-40, a marker of microglial activation, in HIV-1 infection.
Michael J Peluso, Victor Valcour, Nittaya Phanuphak, Jintanat Ananworanich, James Lk Fletcsher et al.
AIDS (London, England), Journal article 2017
Journal article

Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.
Elham Rahimy, Fang-Yong Li, Lars Hagberg, Dietmar Fuchs, Kevin Robertson et al.
The Journal of infectious diseases, Journal article 2017
Journal article

Showing 1 - 10 of 155

Page Manager: Webmaster|Last update: 4/19/2017
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?